Equity Overview
Price & Market Data
Price: $4.48
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $161,010,304
Volume: 0
Performance Metrics
1 Week: 45.93%
1 Month: -12.50%
3 Months: -25.21%
6 Months: -32.92%
1 Year: -32.92%
YTD: -19.71%
Company Details
Employees: 136
Sector: Health technology
Industry: Medical specialties
Country: Australia
Details
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.